These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 34429654)

  • 1. Development of a New Recurrence-Free Survival Prediction Nomogram for Patients with Primary Non-Muscle-Invasive Bladder Cancer Based on Preoperative Controlling Nutritional Status Score.
    Zhao L; Sun J; Wang K; Tai S; Hua R; Yu Y; Fan Y; Huang J
    Cancer Manag Res; 2021; 13():6473-6487. PubMed ID: 34429654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prognostic significance of preoperative platelet-to-lymphocyte ratio and interleukin-6 level in non-muscle invasive bladder cancer.
    Wang X; Zhang S; Sun Y; Cai L; Zhang J
    Int J Biol Markers; 2024 Jun; ():3936155241261719. PubMed ID: 38859794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Geriatric nutritional risk index as a prognostic factor in elderly patients with non-muscle-invasive bladder cancer: a propensity score-matched study.
    Wu J; Cheng X; Yang H; Xiao S; Xu L; Zhang C; Huang W; Jiang C; Wang G
    Int Urol Nephrol; 2024 May; 56(5):1627-1637. PubMed ID: 38177927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nomogram for customized recurrence prediction in primary non-muscle-invasive bladder cancer based on routine blood and urine parameters.
    He Y; Pan C; Zhang Y; Lv M; Yang B
    BMC Urol; 2024 Mar; 24(1):67. PubMed ID: 38528549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic Potential of the Preoperative Controlling Nutritional Status (CONUT) Score in Predicting Survival of Patients with Cancer: A Systematic Review.
    Kheirouri S; Alizadeh M
    Adv Nutr; 2021 Feb; 12(1):234-250. PubMed ID: 32910812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The CONUT score is associated with the pathologic grade in non-small cell lung cancer.
    Onodera K; Notsuda H; Watanabe T; Watanabe Y; Suzuki T; Hirama T; Oishi H; Niikawa H; Noda M; Okada Y
    Surg Today; 2024 May; ():. PubMed ID: 38709286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of Controlling Nutritional Status score for postoperative complications and biochemical recurrence in prostate cancer patients undergoing laparoscopic radical prostatectomy.
    Xiong T; Ye X; Zhu G; Cao F; Cui Y; Song L; Wang M; Wasilijiang W; Xing N; Niu Y
    Curr Urol; 2024 Mar; 18(1):43-48. PubMed ID: 38505164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Prognostic Index Derived From LASSO-Selected Preoperative Inflammation and Nutritional Markers for Non-Muscle-Invasive Bladder Cancer.
    Li D; Wu R; Wang J; Ye J; Yu Q; Feng D; Han P
    Clin Genitourin Cancer; 2024 Jun; 22(3):102061. PubMed ID: 38519296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Nomogram Model for Stratifying the Risk of Recurrence in Patients with Meningioma After Surgery.
    Mo G; Jiang Q; Bao Y; Deng T; Mo L; Huang Q
    World Neurosurg; 2023 Aug; 176():e644-e650. PubMed ID: 37271256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishment and validation of a clinicopathological prediction model for postoperative recurrence of stage IA lung adenocarcinoma.
    Zhang X; Yang J; Li S; Ao Y; Zhong L; Liu X; Luo K; Hu Y
    J Thorac Dis; 2024 May; 16(5):3061-3074. PubMed ID: 38883613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of Thrombocyte/Lymphocyte Ratio and Aspartate Transaminase/Alanine Transaminase (De Ritis) Ratio in Prediction of Recurrence and Progression in Non-muscle Invasive Bladder Cancer.
    Avcı MA; Arslan B; Arslan O; Özdemir E
    Cureus; 2024 Apr; 16(4):e59299. PubMed ID: 38813272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of tumor recurrence after surgical resection of ampullary adenocarcinoma using magnetic resonance imaging.
    Lee S; Lee JE; Kim KD; Hwang JA; Choi SY; Moon JE; Kim MJ
    Eur Radiol; 2024 Mar; ():. PubMed ID: 38536460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High Androgen Receptor mRNA Expression Is Independently Associated with Prolonged Cancer-Specific and Recurrence-Free Survival in Stage T1 Bladder Cancer.
    Sikic D; Breyer J; Hartmann A; Burger M; Erben P; Denzinger S; Eckstein M; Stöhr R; Wach S; Wullich B; Keck B; Wirtz RM; Otto W
    Transl Oncol; 2017 Jun; 10(3):340-345. PubMed ID: 28342317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical calculator based on CT and clinicopathologic characteristics predicts short-term prognosis following resection of microsatellite-stabilized diffuse gastric cancer.
    Liu P; Ding P; Guo H; Yang J; Wu H; Wu J; Yang P; Zhao Q
    Abdom Radiol (NY); 2024 May; ():. PubMed ID: 38727742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Controlling Nutritional Status (CONUT) Score as a Predictor of Local Recurrence in Patients Underwent Partial Nephrectomy Alongside the R.E.N.A.L. Nephrometry Score.
    Yorulmaz EM; Köse O; Özcan S; Görgel SN; Akın Y
    Urol J; 2024 Jul; ():. PubMed ID: 38978464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between Permanent Catheter Patency and Nutrient Score in Patients Aged >75 Years Requiring Renal Replacement Therapy.
    Kim MJ; Hwang Y; Jeon JW; Kim HR; Han S; Park H; Lee EJ; Ham YR; Na KR; Park H; Choi DE
    J Clin Med; 2024 Mar; 13(6):. PubMed ID: 38541789
    [No Abstract]   [Full Text] [Related]  

  • 17. The grade of systemic inflammation, immune inhibition, and gut dysbiosis as prognostic factors for bladder cancer recurrence: a metabolomics approach.
    Petrella G; Ciufolini G; Lentini S; Montorsi F; Salonia A; Pieri M; Albisinni S; Vago R; Cicero DO
    Minerva Urol Nephrol; 2024 Jul; ():. PubMed ID: 38949559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MKI67 with arterial hypertension predict a poor survival for prostate cancer patients, a real-life investigation.
    Zhou Y; Chen W; Jiang H; Zhang Y; Ma Z; Wang Z; Xu C; Jiang M; Chen J; Cao Z
    Clin Transl Oncol; 2024 May; ():. PubMed ID: 38789889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene Screening for Prognosis of Non-Muscle-Invasive Bladder Carcinoma under Competing Risks Endpoints.
    Ke C; Bandyopadhyay D; Sarkar D
    Cancers (Basel); 2023 Jan; 15(2):. PubMed ID: 36672328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Controlling Nutritional Status Score Before Receiving Treatment as a Prognostic Indicator for Patients With Urothelial Cancer: An Exploration Evaluation Methods.
    Peng L; Du C; Meng C; Li J; You C; Li X; Zhao P; Cao D; Li Y
    Front Oncol; 2021; 11():702908. PubMed ID: 34722249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.